High frequency of mitochondrial complex I mutations in Parkinson’s disease and aging

Idiopathic Parkinson's disease (PD) involves a systemic loss of activity of complex I of the mitochondrial electron transport chain. This biochemical lesion plays a key pathogenic role. Transfer of PD mitochondrial DNA recapitulates this loss of activity and several other pathogenic features of PD suggesting that this lesion may arise, at least in part, from mitochondrial DNA. We investigated this possibility by an extensive clonal sequencing of the seven mitochondrial genes encoding complex I subunits in PD and age-matched control frontal cortex. Each gene was completely sequenced an average of 94.4 times for each subject. Aminoacid-changing mutations were found at the frequency of 59.3 per million bases in both PD and controls, corresponding to approximately 32% of the mitochondrial genomes in the average sample having at least one mutation in a complex I gene. Individual low frequency mutations had an abundance of 1-10%. Significant interindividual variation in mutation frequency was observed. Several aminoacid-changing mutations were identified and multiple PD brains but not in controls. Genetic algorithm analysis detected areas in ND genes with a higher mutation frequency in PD that allowed differentiation of PD from controls. Total mutational burden due to low-abundance heteroplasmy is high and may play a role in human disease.

[1]  N. Hattori,et al.  Genotype in the 24-kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson disease. , 1998, Genomics.

[2]  R. Swerdlow,et al.  Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family , 1998, Annals of neurology.

[3]  H. Yoshino,et al.  Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease , 1992, Journal of neural transmission. Parkinson's disease and dementia section.

[4]  K K Kidd,et al.  Modeling of heteroduplex formation during PCR from mixtures of DNA templates. , 1992, PCR methods and applications.

[5]  M. Graeber,et al.  Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease , 1998, Neurogenetics.

[6]  K. Ohno,et al.  Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease. , 1991, Biochemical and biophysical research communications.

[7]  C. Fall,et al.  Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. , 1997, Biochimica et biophysica acta.

[8]  I. Nelson,et al.  The mitochondrial DNA G13513A transition in ND5 is associated with a LHON/MELAS overlap syndrome and may be a frequent cause of MELAS , 1999, Annals of neurology.

[9]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[10]  I. D. de Coo,et al.  A 4–base pair deletion in the mitochondrial cytochrome b gene associated with parkinsonism/MELAS overlap syndrome , 1999, Annals of neurology.

[11]  D. Middleton,et al.  mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish , 2003, Experimental Gerontology.

[12]  Noriyuki Fuku,et al.  Golden mean to longevity: Rareness of mitochondrial cytochrome b variants in centenarians but not in patients with Parkinson's disease , 2002, Journal of neuroscience research.

[13]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[14]  K. Ohno,et al.  Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. , 1990, Biochemical and biophysical research communications.

[15]  S. Dimauro,et al.  Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H. Checkoway,et al.  Mitochondrial ND1 sequence analysis and association of the T4216C mutation with Parkinson's disease. , 2000, Neurotoxicology.

[17]  M. Beal,et al.  Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[18]  T. Montine,et al.  Mitochondrial DNA Deletions/Rearrangements in Parkinson Disease and Related Neurodegenerative Disorders , 2002, Journal of neuropathology and experimental neurology.

[19]  D. Wallace,et al.  Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. , 1992, Mutation research.

[20]  J. Braman,et al.  PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases. , 1996, Nucleic acids research.

[21]  D. Turnbull,et al.  Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease , 1991, Journal of the Neurological Sciences.

[22]  Robert E. Davis,et al.  Altered Calcium Homeostasis in Cells Transformed by Mitochondria from Individuals with Parkinson's Disease , 1997, Journal of neurochemistry.

[23]  P. Modrich,et al.  DNA mismatch correction in a defined system. , 1989, Science.

[24]  K. Ohno,et al.  Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis. , 1990, Biochemical and biophysical research communications.

[25]  J. Smeitink,et al.  Respiratory chain complex I deficiency. , 2001, American journal of medical genetics.

[26]  R. Swerdlow,et al.  Abnormal Mitochondrial Morphology in Sporadic Parkinson's and Alzheimer's Disease Cybrid Cell Lines , 2000, Experimental Neurology.

[27]  M. Suter,et al.  Fragmented mitochondrial DNA is the predominant carrier of oxidized DNA bases. , 1999, Biochemistry.

[28]  H. Reichmann,et al.  Novel mitochondrial DNA mutations in Parkinson's disease , 2002, Journal of Neural Transmission.

[29]  S. Dimauro,et al.  A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy , 2000, Annals of neurology.

[30]  W. Fang,et al.  Methyl-directed Repair of Mismatched Small Heterologous Sequences in Cell Extracts from Escherichia coli * , 1997, The Journal of Biological Chemistry.

[31]  W. Parker,et al.  Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies , 2004, Journal of neurochemistry.

[32]  W. Nicklas,et al.  Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1985, Life sciences.

[33]  G. Wooten,et al.  Maternal inheritance in Parkinson's disease , 1997, Annals of neurology.

[34]  M. Beal,et al.  Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. , 1994, Genomics.

[35]  C. Marsden,et al.  Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. , 1992, Brain : a journal of neurology.

[36]  B. Ames,et al.  Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Montine,et al.  The mitochondrial common deletion in Parkinson's disease and related movement disorders. , 2002, Parkinsonism & related disorders.

[38]  Xuhua Xia,et al.  Protein structure, neighbor effect, and a new index of amino acid dissimilarities. , 2002, Molecular biology and evolution.

[39]  C. Marsden,et al.  Mitochondrial Complex I Deficiency in Parkinson's Disease , 1990, Lancet.

[40]  K. Marder,et al.  Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson’s disease , 2000, Neurology.

[41]  S. Dimauro,et al.  Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. , 1997, Biochemical and biophysical research communications.

[42]  K. Jellinger,et al.  Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. , 1991, Molecular and chemical neuropathology.

[43]  M. Beal,et al.  High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. , 2002, Human molecular genetics.

[44]  M. Beal,et al.  Sequence analysis of the entire mitochondrial genome in Parkinson's disease. , 2002, Biochemical and biophysical research communications.

[45]  T. Chase,et al.  No evidence for altered muscle mitochondrial function in Parkinson's disease. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[46]  N Howell,et al.  Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Radman,et al.  Methyl-directed repair of frameshift mutations in heteroduplex DNA. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Masashi Tanaka Mitochondrial genotypes and cytochrome b variants associated with longevity or Parkinson's disease , 2002, Journal of Neurology.

[49]  A. Bhagwat,et al.  Cooperation and competition in mismatch repair: very short‐patch repair and methyl‐directed mismatch repair in Escherichia coli , 2002, Molecular microbiology.

[50]  Gary E. Gibson,et al.  Low mutational burden of individual acquired mitochondrial DNA mutations in brain. , 2001, Genomics.

[51]  J. Parks,et al.  Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.

[52]  P. Modrich,et al.  Methyl-directed DNA mismatch correction. , 1989, The Journal of biological chemistry.

[53]  D. Turnbull,et al.  Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA , 1999, Nature Genetics.

[54]  R. Swerdlow,et al.  Origin and functional consequences of the complex I defect in Parkinson's disease , 1996, Annals of neurology.

[55]  J. Cooper,et al.  Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease , 1998, Annals of neurology.

[56]  C. Filley,et al.  Reduced platelet cytochrome c oxidase activity in Alzheimer's disease , 1994, Neurology.

[57]  Phillip Nagley,et al.  Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: lack of change of copy number with age. , 2003, Nucleic acids research.

[58]  M. Polz,et al.  Heteroduplexes in mixed-template amplifications: formation, consequence and elimination by 'reconditioning PCR'. , 2002, Nucleic acids research.

[59]  Dominic Thyagarajan,et al.  Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease , 2003, Annals of neurology.

[60]  M. Jensen,et al.  Effect of PCR conditions on the formation of heteroduplex and single-stranded DNA products in the amplification of bacterial ribosomal DNA spacer regions. , 1993, PCR methods and applications.

[61]  Margaret A. Johnson,et al.  Role of mitochondrial DNA mutations in human aging: Implications for the central nervous system and muscle , 1998, Annals of neurology.

[62]  C. Marín,et al.  Mitochondria1 respiratory chain activity in skeletal muscle from patients with Parkinson's disease , 1993, Neurology.

[63]  Jean-Pierre Mazat,et al.  Mitochondrial threshold effects. , 2003, The Biochemical journal.

[64]  D. Turnbull,et al.  Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism? , 2002, The Lancet.

[65]  C. Marsden,et al.  Mitochondrial function in Parkinson's disease , 1992, Annals of neurology.

[66]  O. Blin,et al.  Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy , 1994, Journal of the Neurological Sciences.

[67]  M. Graeber,et al.  Parkinson disease: analysis of mitochondrial DNA in monozygotic twins , 2000, Neurogenetics.

[68]  Robert Hill,et al.  Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease , 1995, Annals of neurology.

[69]  R. Benecke,et al.  Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. , 1993, Brain : a journal of neurology.

[70]  P. Modrich DNA mismatch correction. , 1987, Annual review of biochemistry.

[71]  D. Murdock,et al.  Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. Graeber,et al.  Two novel point mutations of mitochondrial tRNA genes in histologically confirmed Parkinson disease , 1999, Neurogenetics.

[73]  T. Ozawa,et al.  Point mutations of mitochondrial genome in Parkinson's disease. , 1995, Brain research. Molecular brain research.

[74]  R. Rosenberg The Molecular and Genetic Basis of Neurological Disease , 1997 .

[75]  Y. Kagawa,et al.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. , 1989, Biochemical and biophysical research communications.

[76]  B. Crain,et al.  Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. , 1993, Genomics.

[77]  C. Filley,et al.  Cytochrome oxidase deficiency in Alzheimer's disease , 1990, Neurology.

[78]  M. Hanna,et al.  Is the mitochondrial complex I ND5 gene a hot‐spot for MELAS causing mutations? , 2003, Annals of neurology.

[79]  A. Torroni,et al.  Mitochondrial oxidative phosphorylation defects in parkinson's disease , 1991, Annals of neurology.

[80]  S. Lewin,et al.  Quantification of mitochondrial DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[81]  P. Mir,et al.  Mitochondrial DNA A4336G Mutation in Alzheimer’s and Parkinson’s Diseases , 2002, European Neurology.

[82]  H. Reichmann,et al.  Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome. , 1994, European neurology.

[83]  D. Wallace,et al.  Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients. , 1996, American journal of medical genetics.